메뉴 건너뛰기




Volumn 21, Issue 1, 2012, Pages 92-95

The kallikrein-kinin system and oxidative stress

Author keywords

angiotensin I converting enzyme; diabetes mellitus complications; kallikrein kinin system; oxidative stress

Indexed keywords

ANGIOTENSIN I; ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; KALLIDIN; KALLIKREIN; KININ; LOSARTAN; MEMBRANE METALLOENDOPEPTIDASE; NITRIC OXIDE; PERINDOPRIL; PROSTAGLANDIN; REACTIVE OXYGEN METABOLITE; VASOPEPTIDASE INHIBITOR;

EID: 83055176421     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e32834d54b1     Document Type: Review
Times cited : (71)

References (45)
  • 1
    • 78249252379 scopus 로고    scopus 로고
    • Kinin B1 receptor upregulation by angiotensin II and endothelin-1 in rat vascular smooth muscle cells: Receptors and mechanisms
    • Morand-Contant M, Anand-Srivastava MB, Couture R. Kinin B1 receptor upregulation by angiotensin II and endothelin-1 in rat vascular smooth muscle cells: receptors and mechanisms. Am J Physiol Heart Circ Physiol 2010; 299:H1625-H1632.
    • (2010) Am J Physiol Heart Circ Physiol , vol.299
    • Morand-Contant, M.1    Anand-Srivastava, M.B.2    Couture, R.3
  • 2
    • 77049085479 scopus 로고    scopus 로고
    • Differential regulation of inducible and endothelial nitric oxide synthase by kinin B1 and B2 receptors
    • Kuhr F, Lowry J, Zhang Y, et al. Differential regulation of inducible and endothelial nitric oxide synthase by kinin B1 and B2 receptors. Neuropeptides 2010; 44:145-154.
    • (2010) Neuropeptides , vol.44 , pp. 145-154
    • Kuhr, F.1    Lowry, J.2    Zhang, Y.3
  • 3
    • 67349177072 scopus 로고    scopus 로고
    • The kallikrein-kinin system in health and in diseases of the kidney
    • Kakoki M, Smithies O. The kallikrein-kinin system in health and in diseases of the kidney. Kidney Int 2009; 75:1019-1030.
    • (2009) Kidney Int , vol.75 , pp. 1019-1030
    • Kakoki, M.1    Smithies, O.2
  • 4
    • 0342829625 scopus 로고
    • Bradykinin and cardiovascular system: Estimation of half-life
    • Saameli K, Eskes TK. Bradykinin and cardiovascular system: estimation of half-life. Am J Physiol 1962; 203:261-265.
    • (1962) Am J Physiol , vol.203 , pp. 261-265
    • Saameli, K.1    Eskes, T.K.2
  • 5
    • 0027175193 scopus 로고
    • Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptides
    • Jaspard E, Wei L, Alhenc-Gelas F. Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptides. J Biol Chem 1993; 268:9496-9503. (Pubitemid 23146003)
    • (1993) Journal of Biological Chemistry , vol.268 , Issue.13 , pp. 9496-9503
    • Jaspard, E.1    Wei, L.2    Alhenc-Gelas, F.3
  • 6
    • 0033667449 scopus 로고    scopus 로고
    • Importance of quantitative genetic variations in the etiology of hypertension
    • Smithies O, Kim HS, Takahashi N, Edgell MH. Importance of quantitative genetic variations in the etiology of hypertension. Kidney Int 2000; 58:2265-2280.
    • (2000) Kidney Int , vol.58 , pp. 2265-2280
    • Smithies, O.1    Kim, H.S.2    Takahashi, N.3    Edgell, M.H.4
  • 8
    • 78649738484 scopus 로고    scopus 로고
    • Genetically determined angiotensin converting enzyme level and myocardial tolerance to ischemia
    • Messadi E, Vincent MP, Griol-Charhbili V, et al. Genetically determined angiotensin converting enzyme level and myocardial tolerance to ischemia. FASEB J 2010; 24:4691-4700.
    • (2010) FASEB J , vol.24 , pp. 4691-4700
    • Messadi, E.1    Vincent, M.P.2    Griol-Charhbili, V.3
  • 10
    • 0025165779 scopus 로고
    • An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels
    • Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86:1343-1346. (Pubitemid 20370444)
    • (1990) Journal of Clinical Investigation , vol.86 , Issue.4 , pp. 1343-1346
    • Rigat, B.1    Hubert, C.2    Alhenc-Gelas, F.3    Cambien, F.4    Corvol, P.5    Soubrier, F.6
  • 11
    • 77049087281 scopus 로고    scopus 로고
    • Plasma kallikrein and angiotensin I-converting enzyme N-and C-terminal domain activities are modulated by the insertion/deletion polymorphism
    • Almeida SS, Barros CC, Moraes MR, et al. Plasma kallikrein and angiotensin I-converting enzyme N-and C-terminal domain activities are modulated by the insertion/deletion polymorphism. Neuropeptides 2010; 44:139-143.
    • (2010) Neuropeptides , vol.44 , pp. 139-143
    • Almeida, S.S.1    Barros, C.C.2    Moraes, M.R.3
  • 12
    • 53749103611 scopus 로고    scopus 로고
    • Angiotensin converting enzyme insertion/deletion polymorphism and renoprotection in diabetic and nondiabetic nephropathies
    • Ruggenenti P, Bettinaglio P, Pinares F, Remuzzi G. Angiotensin converting enzyme insertion/deletion polymorphism and renoprotection in diabetic and nondiabetic nephropathies. Clin J Am Soc Nephrol 2008; 3:1511-1525.
    • (2008) Clin J Am Soc Nephrol , vol.3 , pp. 1511-1525
    • Ruggenenti, P.1    Bettinaglio, P.2    Pinares, F.3    Remuzzi, G.4
  • 13
    • 65649108517 scopus 로고    scopus 로고
    • Significance of genetic polymorphisms of the reninangiotensin-aldosterone system in cardiovascular and renal disease
    • Rudnicki M, Mayer G. Significance of genetic polymorphisms of the reninangiotensin-aldosterone system in cardiovascular and renal disease. Pharmacogenomics 2009; 10:463-476.
    • (2009) Pharmacogenomics , vol.10 , pp. 463-476
    • Rudnicki, M.1    Mayer, G.2
  • 14
    • 35448931632 scopus 로고    scopus 로고
    • Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE
    • DOI 10.1016/j.ejphar.2007.07.061, PII S0014299907008540
    • Ceconi C, Francolini G, Olivares A, et al. Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE. Eur J Pharmacol 2007; 577:1-6. (Pubitemid 47632513)
    • (2007) European Journal of Pharmacology , vol.577 , Issue.1-3 , pp. 1-6
    • Ceconi, C.1    Francolini, G.2    Olivares, A.3    Comini, L.4    Bachetti, T.5    Ferrari, R.6
  • 15
    • 74949129329 scopus 로고    scopus 로고
    • Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function
    • Erdös EG, Tan F, Skidgel RA. Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function. Hypertension 2010; 55:214-220.
    • (2010) Hypertension , vol.55 , pp. 214-220
    • Erdös, E.G.1    Tan, F.2    Skidgel, R.A.3
  • 16
    • 77956644609 scopus 로고    scopus 로고
    • The RAAS in the pathogenesis and treatment of diabetic nephropathy
    • Ruggenenti P, Cravedi P, Remuzzi G. The RAAS in the pathogenesis and treatment of diabetic nephropathy. Nat Rev Nephrol 2010; 6:319-330.
    • (2010) Nat Rev Nephrol , vol.6 , pp. 319-330
    • Ruggenenti, P.1    Cravedi, P.2    Remuzzi, G.3
  • 17
    • 0037446690 scopus 로고    scopus 로고
    • Vasopeptidase inhibitor omapatrilat induces profound insulin sensitization and increases myocardial glucose uptake in Zucker fatty rats: Studies comparing a vasopeptidase inhibitor, angiotensin-converting enzyme inhibitor, and angiotensin II type I receptor blocker
    • DOI 10.1161/01.CIR.0000062646.09566.CC
    • Wang CH, Leung N, Lapointe N, et al. Vasopeptidase inhibitor omapatrilat induces profound insulin sensitization and increases myocardial glucose uptake in Zucker fatty rats: studies comparing a vasopeptidase inhibitor, angiotensin-converting enzyme inhibitor, and angiotensin II type I receptor blocker. Circulation 2003; 107:1923-1929. (Pubitemid 36444136)
    • (2003) Circulation , vol.107 , Issue.14 , pp. 1923-1929
    • Wang, C.-H.1    Leung, N.2    Lapointe, N.3    Szeto, L.4    Uffelman, K.D.5    Giacca, A.6    Rouleau, J.L.7    Lewis, G.F.8
  • 18
    • 4644278885 scopus 로고    scopus 로고
    • Nephroprotection in Zucker diabetic fatty rats by vasopeptidase inhibition is partly bradykinin B2 receptor dependent
    • DOI 10.1038/sj.bjp.0705884
    • Schäfer S, Schmidts HL, Bleich M, et al. Nephroprotection in Zucker diabetic fatty rats by vasopeptidase inhibition is partly bradykinin B2 receptor dependent. Br J Pharmacol 2004; 143:27-32. (Pubitemid 39280021)
    • (2004) British Journal of Pharmacology , vol.143 , Issue.1 , pp. 27-32
    • Schafer, S.1    Schmidts, H.-L.2    Bleich, M.3    Busch, A.E.4    Linz, W.5
  • 19
    • 45149109175 scopus 로고    scopus 로고
    • Pharmacological blockade of B2-kinin receptor reduces renal protective effect of angiotensin-converting enzyme inhibition in db/db mice model
    • Buléon M, Allard J, Jaafar A, et al. Pharmacological blockade of B2-kinin receptor reduces renal protective effect of angiotensin-converting enzyme inhibition in db/db mice model. Am J Physiol Renal Physiol 2008; 294:F1249-F1256.
    • (2008) Am J Physiol Renal Physiol , vol.294
    • Buléon, M.1    Allard, J.2    Jaafar, A.3
  • 20
    • 77955373707 scopus 로고    scopus 로고
    • Cardioprotective properties of bradykinin: Role of the B(2) receptor
    • Manolis AJ, Marketou ME, Gavras I, Gavras H. Cardioprotective properties of bradykinin: role of the B(2) receptor. Hypertens Res 2010; 33:772-777.
    • (2010) Hypertens Res , vol.33 , pp. 772-777
    • Manolis, A.J.1    Marketou, M.E.2    Gavras, I.3    Gavras, H.4
  • 21
    • 0034619547 scopus 로고    scopus 로고
    • Myocardial protection by preconditioning of heart with losartan, an angiotensin II type 1-receptor blocker: Implication of bradykinin-dependent and bradykinin-independent mechanisms
    • Sato M, Engelman RM, Otani H, et al. Myocardial protection by preconditioning of heart with losartan, an angiotensin II type 1-receptor blocker: implication of bradykinin-dependent and bradykinin-independent mechanisms. Circulation 2000; 102:346-351.
    • (2000) Circulation , vol.102 , pp. 346-351
    • Sato, M.1    Engelman, R.M.2    Otani, H.3
  • 22
    • 79951674873 scopus 로고    scopus 로고
    • The angiotensin II type 1 receptor antagonist losartan binds and activates bradykinin B2 receptor signaling
    • Bonde MM, Olsen KB, Erikstrup N, et al. The angiotensin II type 1 receptor antagonist losartan binds and activates bradykinin B2 receptor signaling. Regul Pept 2011; 167:21-25.
    • (2011) Regul Pept , vol.167 , pp. 21-25
    • Bonde, M.M.1    Olsen, K.B.2    Erikstrup, N.3
  • 23
    • 33646408788 scopus 로고    scopus 로고
    • Senescence-associated phenotypes in Akita diabetic mice are enhanced by absence of bradykinin B2 receptors
    • Kakoki M, Kizer CM, Yi X, et al. Senescence-associated phenotypes in Akita diabetic mice are enhanced by absence of bradykinin B2 receptors. J Clin Invest 2006; 116:1302-1309.
    • (2006) J Clin Invest , vol.116 , pp. 1302-1309
    • Kakoki, M.1    Kizer, C.M.2    Yi, X.3
  • 26
    • 66649088302 scopus 로고    scopus 로고
    • Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy
    • Westermann D, Walther T, Savvatis K, et al. Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy. Diabetes 2009; 58:1373-1381.
    • (2009) Diabetes , vol.58 , pp. 1373-1381
    • Westermann, D.1    Walther, T.2    Savvatis, K.3
  • 27
    • 58249110409 scopus 로고    scopus 로고
    • Delayed blockade of the kinin B1 receptor reduces renal inflammation and fibrosis in obstructive nephropathy
    • Klein J, Gonzalez J, Duchene J, et al. Delayed blockade of the kinin B1 receptor reduces renal inflammation and fibrosis in obstructive nephropathy. FASEB J 2009; 23:134-142.
    • (2009) FASEB J , vol.23 , pp. 134-142
    • Klein, J.1    Gonzalez, J.2    Duchene, J.3
  • 28
    • 79956019655 scopus 로고    scopus 로고
    • Bradykinin receptor 1 activation exacerbates experimental focal and segmental glomerulosclerosis
    • Pereira RL, Buscariollo BN, Correa-Costa M, et al. Bradykinin receptor 1 activation exacerbates experimental focal and segmental glomerulosclerosis. Kidney Int 2011; 79:1217-1227.
    • (2011) Kidney Int , vol.79 , pp. 1217-1227
    • Pereira, R.L.1    Buscariollo, B.N.2    Correa-Costa, M.3
  • 30
    • 77953471168 scopus 로고    scopus 로고
    • Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice
    • Kakoki M, Sullivan KA, Backus C, et al. Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice. Proc Natl Acad Sci USA 2010; 107:10190-10195.
    • (2010) Proc Natl Acad Sci USA , vol.107 , pp. 10190-10195
    • Kakoki, M.1    Sullivan, K.A.2    Backus, C.3
  • 32
    • 77954930286 scopus 로고    scopus 로고
    • Loss of bradykinin signaling does not accelerate the development of cardiac dysfunction in type 1 diabetic Akita mice
    • Wende AR, Soto J, Olsen CD, et al. Loss of bradykinin signaling does not accelerate the development of cardiac dysfunction in type 1 diabetic Akita mice. Endocrinology 2010; 151:3536-3542.
    • (2010) Endocrinology , vol.151 , pp. 3536-3542
    • Wende, A.R.1    Soto, J.2    Olsen, C.D.3
  • 35
    • 43049163718 scopus 로고    scopus 로고
    • Free radicals and senescence
    • Lu T, Finkel T. Free radicals and senescence. Exp Cell Res 2008; 314:1918-1922.
    • (2008) Exp Cell Res , vol.314 , pp. 1918-1922
    • Lu, T.1    Finkel, T.2
  • 36
    • 77958535818 scopus 로고    scopus 로고
    • Kinin B1 receptor enhances the oxidative stress in a rat model of insulin resistance: Outcome in hypertension, allodynia and metabolic complications
    • Dias JP, Talbot S, Séné cal J, et al. Kinin B1 receptor enhances the oxidative stress in a rat model of insulin resistance: outcome in hypertension, allodynia and metabolic complications. PLoS One 2010; 5:e12622.
    • (2010) PLoS One , vol.5
    • Dias, J.P.1    Talbot, S.2    Sénécal, J.3
  • 39
    • 79951864902 scopus 로고    scopus 로고
    • A novel pathway for receptormediated posttranslational activation of inducible nitric oxide synthase
    • Brovkovych V, Zhang Y, Brovkovych S, et al. A novel pathway for receptormediated posttranslational activation of inducible nitric oxide synthase. J Cell Mol Med 2011; 15:258-269.
    • (2011) J Cell Mol Med , vol.15 , pp. 258-269
    • Brovkovych, V.1    Zhang, Y.2    Brovkovych, S.3
  • 41
    • 79952143828 scopus 로고    scopus 로고
    • A modest decrease in endothelial NOS in mice comparable to that associated with human NOS3 variants exacerbates diabetic nephropathy
    • Wang CH, Li F, Hiller S, et al. A modest decrease in endothelial NOS in mice comparable to that associated with human NOS3 variants exacerbates diabetic nephropathy. Proc Natl Acad Sci USA 2011; 108:2070-2075.
    • (2011) Proc Natl Acad Sci USA , vol.108 , pp. 2070-2075
    • Wang, C.H.1    Li, F.2    Hiller, S.3
  • 42
    • 59849109480 scopus 로고    scopus 로고
    • Bradykinin protects against oxidative stress-induced endothelial cell senescence
    • Oeseburg H, Iusuf D, van der Harst P, et al. Bradykinin protects against oxidative stress-induced endothelial cell senescence. Hypertension 2009; 53:417-422.
    • (2009) Hypertension , vol.53 , pp. 417-422
    • Oeseburg, H.1    Iusuf, D.2    Van Der Harst, P.3
  • 43
    • 39349102362 scopus 로고    scopus 로고
    • Prostacyclin protects renal tubular cells from gentamicin-induced apoptosis via a PPARalpha-dependent pathway
    • Hsu YH, Chen CH, Hou CC, et al. Prostacyclin protects renal tubular cells from gentamicin-induced apoptosis via a PPARalpha-dependent pathway. Kidney Int 2008; 73:578-587.
    • (2008) Kidney Int , vol.73 , pp. 578-587
    • Hsu, Y.H.1    Chen, C.H.2    Hou, C.C.3
  • 44
    • 0031081639 scopus 로고    scopus 로고
    • Effects of cicaprost and fosinopril on the progression of rat diabetic nephropathy
    • DOI 10.1016/S0895-7061(96)00319-6, PII S0895706196003196
    • Villa E, Rabano A, Ruilope LM, et al. Effects of cicaprost and fosinopril on the progression of rat diabetic nephropathy. Am J Hypertens 1997; 10:202-208. (Pubitemid 27084632)
    • (1997) American Journal of Hypertension , vol.10 , Issue.2 , pp. 202-208
    • Villa, E.1    Rabano, A.2    Ruilope, L.M.3    Garcia-Robles, R.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.